NewsMeter

MIRA Pharmaceuticals 2026 annual vote: 63.06% quorum, all proposals approved

9/17/2026

26,499,076 shares of MIRA Pharmaceuticals, Inc.

(Nasdaq: MIRA) common stock were present or represented by proxy at the company's 2026 Annual Meeting of Stockholders on September 11, 2026, representing 63.06% of the 42,022,087 shares outstanding as of the July 21, 2026 record date.

All three proposals on the ballot passed.

Director vote Five directors were returned to the board: Erez Aminov, Matthew Pratt Whalen, Matthew Del Giudice, M.D., Denil Nanji Shekhat, M.D., and Edward MacPherson, each to serve until the next annual meeting or until their successors are duly elected and qualified.